The Valley Desk

NCT04195750 · Interventional trial

A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

Overall registry status Active not recruiting

Phase 3

Conditions Carcinoma, Renal Cell

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov